ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (NASDAQ: ARYD) is a blank-check company formed to pursue a business combination in the life sciences and healthcare sector. The SPAC completed its initial public offering in 2021 and is sponsored by ARYA Sciences Holdings IV LLC, a vehicle affiliated with Perceptive Advisors, the New York-based healthcare-focused investment manager that has backed the broader ARYA Sciences SPAC series. The company filed an 8-K/A amendment with the Securities and Exchange Commission on September 29, 2021, under accession number 0001104659-21-120808. ARYD targets innovative life sciences businesses consistent with the sponsor's deep domain expertise in biopharmaceuticals and healthcare technology. Visit SpacDesk and sign up for full data, filings, and deal-tracking on ARYD and hundreds of other SPACs.